FIRE ANT - 54575-315-02 - (solenopsis invicta)

Alphabetical Index


Drug Information of FIRE ANT

Product NDC: 54575-315
Proprietary Name: FIRE ANT
Non Proprietary Name: solenopsis invicta
Active Ingredient(s): 1    g/20mL & nbsp;   solenopsis invicta
Administration Route(s): PERCUTANEOUS; SUBCUTANEOUS
Dosage Form(s): INJECTION, SOLUTION
Coding System: National Drug Codes(NDC)

Labeler Information of FIRE ANT

Product NDC: 54575-315
Labeler Name: Allergy Laboratories, Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: BLA101376
Marketing Category: BLA
Start Marketing Date: 19671207

Package Information of FIRE ANT

Package NDC: 54575-315-02
Package Description: 2 mL in 1 VIAL, MULTI-DOSE (54575-315-02)

NDC Information of FIRE ANT

NDC Code 54575-315-02
Proprietary Name FIRE ANT
Package Description 2 mL in 1 VIAL, MULTI-DOSE (54575-315-02)
Product NDC 54575-315
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name solenopsis invicta
Dosage Form Name INJECTION, SOLUTION
Route Name PERCUTANEOUS; SUBCUTANEOUS
Start Marketing Date 19671207
Marketing Category Name BLA
Labeler Name Allergy Laboratories, Inc.
Substance Name SOLENOPSIS INVICTA
Strength Number 1
Strength Unit g/20mL
Pharmaceutical Classes Non-Standardized Insect Venom Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Insect Proteins [Chemical/Ingredient],Ant Venoms [Chemical/Ingredient],Allergens [Chemical/Ingredient]

Complete Information of FIRE ANT


General Information